Clinical trial · Interventional
Benefit of Roux-en-Y (R-Y) Reconstruction After Pancreaticoduodenectomy
Benefit of R-Y Reconstruction After Pancreaticoduodenectomy
NCT00906802CI-TRIAL-00002487unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
One of the most common complications of pancreaticoduodenectomy (PD) is delayed gastric emptying (DGE), otherwise known as "gastroparesis," which is not fatal but results in prolonged hospital stay and increased hospital costs. Delayed gastric emptying is defined as nasogastric decompression after postoperative day (POD) 10 or a failure to tolerate a regular diet after POD 14. The incidence of DGE has been reported to range from 5% to 72%.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pancreatic Cancer | Malignant Pancreatic Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| R-Y reconstruction | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- R-Y reconstruction
- description
- the reconstruction was performed by R-Y anastomosis
- interventionNames
- Procedure: R-Y reconstruction
- type
- NO_INTERVENTION
- label
- conventional reconstruction
- description
- the anastomosis was performed by B-II
Primary outcomes (1)
- measure
- the incidence of DGE
- timeFrame
- 3-6 months
Secondary outcomes (1)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 30 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * These patients were to undergo elective pancreatic head resection for the treatment of periampullary mass Exclusion Criteria: * A body weight loss greater than 10% during the six months prior to surgery * The presence of distant metastases * Seriously impaired function of vital organs due to respiratory, renal or heart disease
References
Publications (0)
Data not yet available
No reference posted for this study.